ArticleCureus2026
Pulmonary Sarcomatoid (Pleomorphic) Carcinoma Presenting As Secondary Spontaneous Pneumothorax in Diffuse Cystic Lung Disease: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary sarcomatoid carcinoma is a rare and aggressive subtype of non-small cell lung cancer associated with poor prognosis and atypical clinical presentations. Spontaneous pneumothorax as an initial manifestation is exceedingly uncommon and may obscure the underlying diagnosis, particularly in patients with diffuse cystic lung disease. This report describes a case of pulmonary sarcomatoid (pleomorphic) carcinoma presenting with secondary spontaneous pneumothorax in the setting of diffuse cystic lung abnormalities, highlighting the diagnostic challenges encountered and the importance of maintaining suspicion for malignancy in atypical presentations. Early tissue diagnosis, multidisciplinary evaluation, and molecular profiling played key roles in guiding definitive management. This case underscores the need to consider lung cancer in patients presenting with spontaneous pneumothorax and atypical parenchymal findings, as timely recognition may permit curative-intent treatment and biomarker-informed systemic therapy in this aggressive malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.